Cargando…

Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant

Detalles Bibliográficos
Autores principales:	Higdon, Melissa M, Baidya, Anurima, Walter, Karoline K, Patel, Minal K, Issa, Hanane, Espié, Emmanuelle, Feikin, Daniel R, Knoll, Maria Deloria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221361/ https://www.ncbi.nlm.nih.gov/pubmed/35752196 http://dx.doi.org/10.1016/S1473-3099(22)00409-1

Ejemplares similares

A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
por: Higdon, Melissa M, et al.
Publicado: (2022)

Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization
por: Feikin, Daniel R., et al.
Publicado: (2023)

Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization
por: Feikin, Daniel R., et al.
Publicado: (2022)

Post-Vaccination Neutralization Responses to Omicron Sub-Variants
por: Jacobsen, Henning, et al.
Publicado: (2022)

Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant
por: Sitaras, Ioannis, et al.
Publicado: (2022)

Post-vaccination T cell immunity to omicron
por: Jacobsen, Henning, et al.
Publicado: (2022)

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
por: Feikin, Daniel R, et al.
Publicado: (2022)

Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
por: Bobrovitz, Niklas, et al.
Publicado: (2023)

Liver injury caused by SARS-CoV-2 Delta and Omicron-variant in Taiwan
por: Jang, Tyng-Yuan
Publicado: (2022)

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection
por: Boucau, Julie, et al.
Publicado: (2022)

Decoupling of omicron variant infections and severe COVID-19
por: Madhi, Shabir A, et al.
Publicado: (2022)

Omicron: a challenge to hybrid immunity – correspondence
por: Niranjan, Ankush K., et al.
Publicado: (2023)

Assessing the Reliability of SARS-CoV-2 Neutralization Studies That Use Post-Vaccination Sera
por: Jacobsen, Henning, et al.
Publicado: (2022)

SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects – correspondence
por: Channabasappa, Nikhil K., et al.
Publicado: (2023)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant
por: Zhao, Xin, et al.
Publicado: (2022)

Emergence of novel omicron hybrid variants: BA(x), XE, XD, XF more than just alphabets
por: Thakur, Pryanka, et al.
Publicado: (2022)

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
por: Takashita, Emi, et al.
Publicado: (2022)

A spike protein S2 antibody efficiently neutralizes the Omicron variant
por: Hu, Jia, et al.
Publicado: (2022)

Characteristics and implications of Omicron variant associated digestive system infections – Correspondence
por: Shi, Yunjie, et al.
Publicado: (2022)

Evaluation of cross-neutralizing antibodies in children infected with omicron sub-variants
por: Peng, Weiyu, et al.
Publicado: (2023)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa
por: Collie, Shirley, et al.
Publicado: (2021)

T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant
por: Choi, Seong Jin, et al.
Publicado: (2022)

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
por: Yu, Jingyou, et al.
Publicado: (2022)

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
por: Hu, Jie, et al.
Publicado: (2022)

Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
por: Destras, Grégory, et al.
Publicado: (2022)

The Omicron COVID‐19 threat to dialysis patients is dramatically lower than previous variants
por: Al Madani, Ayman Kamal, et al.
Publicado: (2022)

Omicron Variant in the Critical Care Units of the Paris Metropolitan Area: The Reality Research Group
por: Vieillard-Baron, Antoine, et al.
Publicado: (2022)

Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant
por: Yamasoba, Daichi, et al.
Publicado: (2023)

Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants
por: Tartof, Sara Y, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
por: Bojkova, Denisa, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
por: Rössler, Annika, et al.
Publicado: (2022)

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
por: Antonelli, Michela, et al.
Publicado: (2022)

Limits of Monoclonal Antibody Treatment in Pregnant Women Complicated with COVID-19 Due to The Omicron Variant
por: Cha, Hyun-Hwa, et al.
Publicado: (2022)

Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2
por: Shen, Yaping, et al.
Publicado: (2022)

Dynamic disease manifestations among individuals infected with SARS-CoV-2 Omicron variant
por: Wang, Peiqin, et al.
Publicado: (2023)

Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
por: Yu, Xiaoqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1fsuk3v7io1d031okc9b41fct9